Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:06 PM
Ignite Modification Date:
2025-12-25 @ 4:40 PM
NCT ID:
NCT01611857
Group ID:
EG001
Title:
Tivantinib+FOLFOX Dose Expansion
Description:
Tivantinib: 360 mg PO BID on Days 1-14 of each 2-week cycle. FOLFOX: (5-FU 400 mg/m\^2, 5-FU continuous IV 2400 mg/m\^2 over 46 hours, leucovorin 400 mg/m\^2 IV, and oxaliplatin 85 mg/m\^2) on Day 1 of each 2-week cycle.
Treatment continued until disease progression or unacceptable toxicity.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
17
Serious Number At Risk:
32
Other Number Affected:
31
Other Number At Risk:
32
Study:
NCT01611857
Results Section:
NCT01611857
Adverse Events Module:
NCT01611857